Annual Drug Patent Expirations for VELSIPITY Velsipity is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are six patents protecting…
The post New patent for Pfizer drug VELSIPITY appeared first on DrugPa…
Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. It is available from one supplier. There are twenty-two patents…
The post New patent for Deciphera Pharms drug QINLOCK appeared first …
Annual Drug Patent Expirations for PIQRAY Piqray is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Novartis drug PIQRAY appeared first on DrugPatentWa…
Annual Drug Patent Expirations for FILSUVEZ Filsuvez is a drug marketed by Amryt and is included in one NDA. It is available from one supplier. The generic ingredient in FILSUVEZ…
The post New patent for AMRYT drug FILSUVEZ appeared first on DrugPatent…
Annual Drug Patent Expirations for ZURZUVAE Zurzuvae is a drug marketed by Biogen Inc and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent for Biogen Inc drug ZURZUVAE appeared first on DrugPatentWa…
Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are twelve patents protecting…
The post New patent for Novartis drug TAFINLAR appeared first on Dr…
Annual Drug Patent Expirations for INCRUSE+ELLIPTA Incruse Ellipta is a drug marketed by Glaxo Grp England and is included in one NDA. It is available from one supplier. There are…
The post New patent for Glaxo Grp drug INCRUSE ELLIPTA appeared first o…
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post New patent for Glaxosmithkline drug TRELEGY ELL…
New patent for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Annual Drug Patent Expirations for AVYCAZ Avycaz is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for Allergan drug AVYCAZ appeared first on DrugPatent…
Annual Drug Patent Expirations for AUVI-Q Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. It is available from three suppliers. There are twenty-four patents…
The post New patent for Kaleo Inc drug AUVI-Q appeared first on DrugPatent…